C.K. McWhorter Opens Conversations With Goldman Sachs A Historic Odyssey In Finance
26 mars 2024 10h29 HE
|
McWhorter Foundation
C.K. McWhorter Opens Conversations With Goldman Sachs A Historic Odyssey In Finance.
Zero Hash Honored by Goldman Sachs for Entrepreneurship
18 oct. 2023 09h00 HE
|
Zero Hash
CHICAGO, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Today, Goldman Sachs (NYSE:GS) is recognizing Zero Hash Founder and CEO, Edward Woodford as one of the Most Exceptional Entrepreneurs of 2023 at its...
Recursion to Participate in Upcoming Investor Conference
01 août 2023 08h30 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Myriad Genetics to Participate in Goldman Sachs Healthcare Conference
07 juin 2023 16h05 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and CEO, will...
InnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare Conference
05 juin 2023 08h00 HE
|
InnovAge
DENVER, June 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors...
Recursion to Participate in Upcoming Investor Conferences
01 juin 2023 08h30 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in...
Revolution Medicines to Participate in TD Cowen 4th Annual Oncology Innovation Summit
24 mai 2023 16h05 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Micron Technology Announces Upcoming Investor Events
04 mai 2023 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, May 04, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that company executives will participate in fireside chats at the following investor events: ...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages The Goldman Sachs Group, Inc. Investors to Inquire About Securities Class Action Investigation – GS
14 févr. 2023 20h00 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Goldman...
SHAREHOLDER ALERT: Morris Kandinov Investigating MAXR, GIRNX, FOX and DESSX; Shareholders are Encouraged to Contact the Firm
14 févr. 2023 11h00 HE
|
Morris Kandinov, LLP
SAN DIEGO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Maxar Technologies Inc., Goldman Sachs International Equity ESG Fund, Fox Corporation, and DWS ESG...